α-enolase: A promising therapeutic and diagnostic tumor target

FEBS Journal

Volumn 278, Issue 7, 2011, Pages 1064-1074

  Capello, Michela ^a   Ferri Borgogno, Sammy ^a   Cappello, Paola ^a   Novelli, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

enolase; cancer; immune response; post translational modifications; tumor associated antigen

Indexed keywords

ALPHA ENOLASE; SIGNAL PEPTIDE; TUMOR ANTIGEN; TUMOR MARKER;

B LYMPHOCYTE; BINDING SITE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; HUMAN; HUMORAL IMMUNITY; MALIGNANT TRANSFORMATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; REVIEW; TRANSCRIPTION REGULATION;

ADAPTIVE IMMUNITY; ANTIGENS, NEOPLASM; HUMANS; NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PLASMINOGEN; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 79952830765     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08025.x     Document Type: Review

References (133)

1. Pancholi V, (2001) Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58, 902-920. (Pubitemid 32652817)
2. Wold F, (1971) Macromolecules: Structure and Function. Prentice-Hall, Englewood Cliffs, NJ.
3. Piast M, Kustrzeba-Wojcicka I, Matusiewicz M, &, Banas T, (2005) Molecular evolution of enolase. Acta Biochim Pol 52, 507-513. (Pubitemid 41133788)
4. Craig SP, Day IN, Thompson RJ, &, Craig IW, (1990) Localisation of neurone-specific enolase (ENO2) to 12p13. Cytogenet Cell Genet 54, 71-73.
5. Feo S, Oliva D, Barbieri G, Xu WM, Fried M, &, Giallongo A, (1990) The gene for the muscle-specific enolase is on the short arm of human chromosome 17. Genomics 6, 192-194. (Pubitemid 20172373)
6. Rider CC, &, Taylor CB, (1975) Enolase isoenzymes. II. Hybridization studies, developmental and phylogenetic aspects. Biochim Biophys Acta 405, 175-187.
7. Fletcher L, Rider CC, &, Taylor CB, (1976) Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys Acta 452, 245-252.
8. Fletcher L, Rider CC, Taylor CB, Adamson ED, Luke BM, &, Graham CF, (1978) Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse. Dev Biol 65, 462-475. (Pubitemid 9004393)
9. Marangos PJ, Zis AP, Clark RL, &, Goodwin FK, (1978) Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res 150, 117-133. (Pubitemid 8367979)
10. Kang HJ, Jung SK, Kim SJ, &, Chung SJ, (2008) Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr D Biol Crystallogr 64, 651-657. (Pubitemid 351872066)
11. Ehinger S, Schubert WD, Bergmann S, Hammerschmidt S, &, Heinz DW, (2004) Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites. J Mol Biol 343, 997-1005. (Pubitemid 39345959)
12. Dudani AK, Cummings C, Hashemi S, &, Ganz PR, (1993) Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 69, 185-196. (Pubitemid 23068243)
13. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, &, Plow EF, (1991) Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30, 1682-1691.
14. Redlitz A, Fowler BJ, Plow EF, &, Miles LA, (1995) The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 227, 407-415.
15. Pancholi V, &, Fischetti VA, (1998) alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273, 14503-14515. (Pubitemid 28319172)
16. Sundstrom P, &, Aliaga GR, (1992) Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J Bacteriol 174, 6789-6799.
17. Pal-Bhowmick I, Mehta M, Coppens I, Sharma S, &, Jarori GK, (2007) Protective properties and surface localization of Plasmodium falciparum enolase. Infect Immun 75, 5500-5508. (Pubitemid 350033640)
18. Felez J, Chanquia CJ, Fabregas P, Plow EF, &, Miles LA, (1993) Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 82, 2433-2441. (Pubitemid 23304267)
19. Lopez-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fabregas P, Jardi M, Merton E, Miles LA, &, Felez J, (2003) Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-enolase. Am J Hematol 72, 234-242. (Pubitemid 36383973)
20. Moscato S, Pratesi F, Sabbatini A, Chimenti D, Scavuzzo M, Passatino R, Bombardieri S, Giallongo A, &, Migliorini P, (2000) Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol 30, 3575-3584. (Pubitemid 32005230)
21. Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, Lohmeyer J, Markart P, &, Preissner KT, (2009) Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 113, 5588-5598.
22. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, &, Kohsaka S, (1994) Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. J Neurochem 63, 2048-2057. (Pubitemid 24369977)
23. Kim JW, &, Dang CV, (2005) Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30, 142-150. (Pubitemid 40332530)
24. Feo S, Arcuri D, Piddini E, Passantino R, &, Giallongo A, (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 473, 47-52. (Pubitemid 30235183)
25. Ray R, &, Miller DM, (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11, 2154-2161. (Pubitemid 21895587)
26. Subramanian A, &, Miller DM, (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275, 5958-5965. (Pubitemid 30115245)
27. Lo Presti M, Ferro A, Contino F, Mazzarella C, Sbacchi S, Roz E, Lupo C, Perconti G, Giallongo A, Migliorini P, et al. (2010) Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma. PLoS ONE 5, e12961.
28. Perconti G, Ferro A, Amato F, Rubino P, Randazzo D, Wolff T, Feo S, &, Giallongo A, (2007) The kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control. Biochim Biophys Acta 1773, 1774-1785. (Pubitemid 350191977)
29. Cappello P, Tomaino B, Chiarle R, Ceruti P, Novarino A, Castagnoli C, Migliorini P, Perconti G, Giallongo A, Milella M, et al. (2009) An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 125, 639-648.
30. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, et al. (2007) Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98, 1234-1240. (Pubitemid 46993544)
31. Seweryn E, Pietkiewicz J, Bednarz-Misa IS, Ceremuga I, Saczko J, Kulbacka J, &, Gamian A, (2009) Localization of enolase in the subfractions of a breast cancer cell line. Z Naturforsch C 64, 754-758.
32. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, &, Banks RE, (2004) Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4, 4019-4031. (Pubitemid 39657475)
33. Yu X, Harris SL, &, Levine AJ, (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66, 4795-4801.
34. Maxwell CA, McCarthy J, &, Turley E, (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci 121, 925-932. (Pubitemid 351639411)
35. Nickel W, (2005) Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614. (Pubitemid 40959689)
36. Lopez-Villar E, Monteoliva L, Larsen MR, Sachon E, Shabaz M, Pardo M, Pla J, Gil C, Roepstorff P, &, Nombela C, (2006) Genetic and proteomic evidences support the localization of yeast enolase in the cell surface. Proteomics 6 (Suppl 1), S107-S118.
37. Pal-Bhowmick I, Krishnan S, &, Jarori GK, (2007) Differential susceptibility of Plasmodium falciparum versus yeast and mammalian enolases to dissociation into active monomers. FEBS J 274, 1932-1945. (Pubitemid 46587994)
38. Dudani AK, &, Ganz PR, (1996) Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 95, 168-178. (Pubitemid 26340247)
39. Kanalas JJ, &, Makker SP, (1991) Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 266, 10825-10829. (Pubitemid 21906879)
40. Hembrough TA, Li L, &, Gonias SL, (1996) Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem 271, 25684-25691. (Pubitemid 26337950)
41. Borza DB, &, Morgan WT, (1997) Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. J Biol Chem 272, 5718-5726. (Pubitemid 27102400)
42. Winram SB, &, Lottenberg R, (1996) The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology 142 (Pt 8), 2311-2320. (Pubitemid 26288107)
43. Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A, &, Waisman DM, (1998) The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 273, 4790-4799. (Pubitemid 28103230)
44. Das R, Burke T, &, Plow EF, (2007) Histone H2B as a functionally important plasminogen receptor on macrophages. Blood 110, 3763-3772. (Pubitemid 350159647)
45. Felez J, (1998) Plasminogen binding to cell surfaces. Fibrinolysis Proteolysis 12, 183-189. (Pubitemid 28539225)
46. Andreasen PA, Egelund R, &, Petersen HH, (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57, 25-40. (Pubitemid 30105328)
47. Lijnen HR, Van Hoef B, Lupu F, Moons L, Car-meliet P, &, Collen D, (1998) Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 18, 1035-1045. (Pubitemid 28323587)
48. Plow EF, Felez J, &, Miles LA, (1991) Cellular regulation of fibrinolysis. Thromb Haemost 66, 32-36.
49. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, &, Seiki M, (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65. (Pubitemid 24216953)
50. Vassalli JD, &, Pepper MS, (1994) Tumour biology. Membrane proteases in focus. Nature 370, 14-15. (Pubitemid 24216941)
51. Plow EF, Freaney DE, Plescia J, &, Miles LA, (1986) The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 103, 2411-2420. (Pubitemid 17216665)
52. Liu KJ, &, Shih NY, (2007) The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. J Cancer Mol 3, 45-48.
53. Saldanha RG, Molloy MP, Bdeir K, Cines DB, Song X, Uitto PM, Weinreb PH, Violette SM, &, Baker MS, (2007) Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy. J Proteome Res 6, 1016-1028. (Pubitemid 46480466)
54. Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, et al. (2009) Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines. J Mol Endocrinol 42, 249-260.
55. Dowling P, Meleady P, Dowd A, Henry M, Glynn S, &, Clynes M, (2007) Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochim Biophys Acta 1774, 93-101. (Pubitemid 46049136)
56. Crippa MP, (2007) Urokinase-type plasminogen activator. Int J Biochem Cell Biol 39, 690-694. (Pubitemid 46366797)
57. Quemener C, Gabison EE, Naimi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchede G, Lebbe C, Calvo F, Menashi S, et al. (2007) Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. Cancer Res 67, 9-15. (Pubitemid 46142753)
58. Siren V, Salmenpera P, Kankuri E, Bizik J, Sorsa T, Tervahartiala T, &, Vaheri A, (2006) Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med 38, 212-220. (Pubitemid 43675586)
59. Smith R, Xue A, Gill A, Scarlett C, Saxby A, Clarkson A, &, Hugh T, (2007) High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. World J Surg 31, 493-502. (Pubitemid 46356075)
60. Hurtado M, Lozano JJ, Castellanos E, Lopez-Fernandez LA, Harshman K, Martinez AC, Ortiz AR, Thomson TM, &, Paciucci R, (2007) Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut 56, 1266-1274. (Pubitemid 47300429)
61. Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, Ampurdanes C, Real FX, &, Navarro P, (2007) Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 170, 1573-1584. (Pubitemid 47339302)
62. Roda O, Chiva C, Espuna G, Gabius HJ, Real FX, Navarro P, &, Andreu D, (2006) A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics 6 (Suppl 1), S36-S41.
63. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, &, Pfreundschuh M, (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92, 11810-11813. (Pubitemid 26014201)
64. Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, &, Cheever MA, (1997) High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol 15, 3363-3367. (Pubitemid 27485856)
65. Tan HT, Low J, Lim SG, &, Chung MC, (2009) Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276, 6880-6904.
66. Anderson KS, &, LaBaer J, (2005) The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 4, 1123-1133, doi:. (Pubitemid 41208670)
67. Caron M, Choquet-Kastylevsky G, &, Joubert-Caron R, (2007) Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 6, 1115-1122. (Pubitemid 47099223)
68. Finn OJ, (2008) Cancer immunology. N Engl J Med 358, 2704-2715.
69. Shih NY, Lai HL, Chang GC, Lin HC, Wu YC, Liu JM, Liu KJ, &, Tseng SW, (2010) Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Jpn J Clin Oncol 40, 663-669.
70. Hanash S, (2003) Harnessing immunity for cancer marker discovery. Nat Biotechnol 21, 37-38. (Pubitemid 36055824)
71. Warburg O, (1930) The Metabolism of Tumours. Constable, London.
72. Vander Heiden MG, Cantley LC, &, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
73. Brown JM, &, Giaccia AJ, (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58, 1408-1416. (Pubitemid 28193601)
74. Lu Z, &, Sack MN, (2008) ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3. J Biol Chem 283, 23410-23418.
75. Sedoris KC, Thomas SD, &, Miller DM, (2010) Hypoxia induces differential translation of enolase/MBP-1. BMC Cancer 10, 157.
76. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, &, Giallongo A, (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271, 32529-32537.
77. Altenberg B, &, Greulich KO, (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020. (Pubitemid 39469126)
78. Tu SH, Chang CC, Chen CS, Tam KW, Wang YJ, Lee CH, Lin HW, Cheng TC, Huang CS, Chu JS, et al. (2010) Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat 121, 539-553.
79. Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, et al. (2003) High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 3, 1863-1873. (Pubitemid 37305880)
80. Kabbage M, Chahed K, Hamrita B, Guillier CL, Trimeche M, Remadi S, Hoebeke J, &, Chouchane L, (2008) Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry. J Biomed Biotechnol 2008, 564127.
81. Malorni L, Cacace G, Cuccurullo M, Pocsfalvi G, Chambery A, Farina A, Di MaroA, Parente A, &, Malorni A, (2006) Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol. Proteomics 6, 5973-5982. (Pubitemid 44851383)
82. Hennipman A, van Oirschot BA, Smits J, Rijksen G, &, Staal GE, (1988) Glycolytic enzyme activities in breast cancer metastases. Tumour Biol 9, 241-248.
83. Hennipman A, Smits J, van Oirschot B, van Houwelingen JC, Rijksen G, Neyt JP, Van Unnik JA, &, Staal GE, (1987) Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol 8, 251-263. (Pubitemid 17162391)
84. Bae SM, Min HJ, Ding GH, Kwak SY, Cho YL, Nam KH, Park CH, Kim YW, Kim CK, Han BD, et al. (2006) Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients. Cancer Res Treat 38, 99-107.
85. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, &, Ahn WS, (2005) Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99, 26-35. (Pubitemid 41354579)
86. Katayama M, Nakano H, Ishiuchi A, Wu W, Oshima R, Sakurai J, Nishikawa H, Yamaguchi S, &, Otsubo T, (2006) Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today 36, 1085-1093. (Pubitemid 44819452)
87. Wong CS, Wong VW, Chan CM, Ma BB, Hui EP, Wong MC, Lam MY, Au TC, Chan WH, Cheuk W, et al. (2008) Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol Rep 20, 89-98.
88. Qi Y, Chiu JF, Wang L, Kwong DL, &, He QY, (2005) Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5, 2960-2971. (Pubitemid 41059772)
89. Zhao J, Chang AC, Li C, Shedden KA, Thomas DG, Misek DE, Manoharan AP, Giordano TJ, Beer DG, &, Lubman DM, (2007) Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol Cell Proteomics 6, 987-999. (Pubitemid 47019400)
90. Govekar RB, D'Cruz AK, Alok Pathak K, Agarwal J, Dinshaw KA, Chinoy RF, Gadewal N, Kannan S, Sirdeshmukh R, Sundaram CS, et al. (2009) Proteomic profiling of cancer of the gingivo-buccal complex: identification of new differentially expressed markers. Proteomics Clin Appl 3, 1451-1462.
91. Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, &, Wu LW, (2010) ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer 46, 1712-1723.
92. Lopez-Pedrera C, Villalba JM, Siendones E, Barbarroja N, Gomez-Diaz C, Rodriguez-Ariza A, Buendia P, Torres A, &, Velasco F, (2006) Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics 6 (Suppl 1), S293-S299.
93. Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, et al. (2008) Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 33, 725-731.
94. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Okita K, Oka M, &, Nakamura K, (2005) Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5, 1686-1692. (Pubitemid 40593274)
95. Li LS, Kim H, Rhee H, Kim SH, Shin DH, Chung KY, Park KS, Paik YK, &, Chang J, (2004) Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. Proteomics 4, 3394-3400. (Pubitemid 39525288)
96. Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X, Li X, Yi H, Li M, Zhu G, et al. (2006) Proteome analysis of human lung squamous carcinoma. Proteomics 6, 547-558. (Pubitemid 43208034)
97. Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF, &, Yi H, (2006) Proteomic analysis of secreted proteins of non-small cell lung cancer. Ai Zheng 25, 1361-1367.
98. Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, &, Sangvanich P, (2009) Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics 6, 229-237.
99. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, et al. (2006) Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 12, 5746-5754. (Pubitemid 44629605)
100. Cao L, Li X, Zhang Y, Peng F, Yi H, Xu Y, &, Wang Q, (2010) Proteomic analysis of human ovarian cancer paclitaxel-resistant cell lines. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35, 286-294.
101. Shen J, Person MD, Zhu J, Abbruzzese JL, &, Li D, (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64, 9018-9026. (Pubitemid 39665512)
102. Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I, &, Nakamura K, (2007) Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 30, 849-855.
103. Rehman I, Azzouzi AR, Catto JW, Allen S, Cross SS, Feeley K, Meuth M, &, Hamdy FC, (2004) Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology 64, 1238-1243. (Pubitemid 39647082)
104. Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, et al. (2010) Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics 7, 17-23.
105. Paik WK, Paik DC, &, Kim S, (2007) Historical review: the field of protein methylation. Trends Biochem Sci 32, 146-152. (Pubitemid 46367693)
106. Spange S, Wagner T, Heinzel T, &, Kramer OH, (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 41, 185-198.
107. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, &, Mann M, (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
108. Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, &, Han DK, (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2, ra46.
109. Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, &, Comb MJ, (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94-101. (Pubitemid 41724631)
110. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203. (Pubitemid 350235027)
111. Molina H, Horn DM, Tang N, Mathivanan S, &, Pandey A, (2007) Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 104, 2199-2204. (Pubitemid 46391375)
112. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, et al. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23, 607-618. (Pubitemid 44205490)
113. Yu LR, Zhu Z, Chan KC, Issaq HJ, Dimitrov DS, &, Veenstra TD, (2007) Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res 6, 4150-4162. (Pubitemid 350158493)
114. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, &, Gygi SP, (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105, 10762-10767.
115. Zhou W, Capello M, Fredolini C, Piemonti L, Liotta LA, Novelli F, &, Petricoin EF, (2010) Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells. J Proteome Res 9, 2929-2936.
116. Yang XJ, &, Seto E, (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31, 449-461.
117. Sahin U, Tureci O, &, Pfreundschuh M, (1997) Serological identification of human tumor antigens. Curr Opin Immunol 9, 709-716. (Pubitemid 27485301)
118. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, &, Schoenberger SP, (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421, 852-856. (Pubitemid 36254145)
119. Tomaino B, Cappello P, Capello M, Fredolini C, Sperduti I, Migliorini P, Salacone P, Novarino A, Giacobino A, Ciuffreda L, et al. (2011) Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer. J Proteome Res 1, 105-112.
120. Cui JW, Li WH, Wang J, Li AL, Li HY, Wang HX, He K, Li W, Kang LH, Yu M, et al. (2005) Proteomics-based identification of human acute leukemia antigens that induce humoral immune response. Mol Cell Proteomics 4, 1718-1724. (Pubitemid 41749265)
121. Zou L, Wu Y, Pei L, Zhong D, Gen M, Zhao T, Wu J, Ni B, Mou Z, Han J, et al. (2005) Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis. Leuk Res 29, 1387-1391. (Pubitemid 41562240)
122. Forgber M, Trefzer U, Sterry W, &, Walden P, (2009) Proteome serological determination of tumor-associated antigens in melanoma. PLoS ONE 4, e5199.
123. Shukla S, Govekar RB, Sirdeshmukh R, Sundaram CS, D'Cruz AK, Pathak KA, Kane SV, &, Zingde SM, (2007) Tumor antigens eliciting autoantibody response in cancer of gingivo-buccal complex. Proteomics Clin Appl 1, 1592-1604.
124. Shukla S, Pranay A, D'Cruz AK, Chaturvedi P, Kane SV, &, Zingde SM, (2009) Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5, 127-135.
125. Ejma M, Misiuk-Hojlo M, Gorczyca WA, Podemski R, Szymaniec S, Kuropatwa M, Rogozinska-Szczepka J, &, Bartnik W, (2008) Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy. Breast Cancer Res Treat 110, 269-271. (Pubitemid 351793877)
126. Jankowska R, Witkowska D, Porebska I, Kuropatwa M, Kurowska E, &, Gorczyca WA, (2004) Serum antibodies to retinal antigens in lung cancer and sarcoidosis. Pathobiology 71, 323-328. (Pubitemid 40082313)
127. Nakanishi T, Takeuchi T, Ueda K, Murao H, &, Shimizu A, (2006) Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J Chromatogr B Analyt Technol Biomed Life Sci 838, 15-20. (Pubitemid 43832210)
128. Ueda K, (2005) Proteome analysis of autoantibodies in sera of patients with cancer. Rinsho Byori 53, 437-445.
129. Dot C, Guigay J, &, Adamus G, (2005) Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol 139, 746-747.
130. Mohammed F, Cobbold M, Zarling AL, Salim M, Barrett-Wilt GA, Shabanowitz J, Hunt DF, Engelhard VH, &, Willcox BE, (2008) Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat Immunol 9, 1236-1243.
131. Sato N, Nabeta Y, Kondo H, Sahara H, Hirohashi Y, Kashiwagi K, Kanaseki T, Sato Y, Rong S, Hirai I, et al. (2000) Human CD8 and CD4 T cell epitopes of epithelial cancer antigens. Cancer Chemother Pharmacol 46 (Suppl), S86-S90.
132. Kondo H, Sahara H, Miyazaki A, Nabeta Y, Hirohashi Y, Kanaseki T, Yamaguchi A, Yamada N, Hirayama K, Suzuki M, et al. (2002) Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells. Jpn J Cancer Res 93, 917-924. (Pubitemid 35012254)
133. Fernandez Madrid F, (2005) Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett 230, 187-198. (Pubitemid 41612462)